Role of nuclear factor kappa B in neuropathological mechanisms
- 1 January 2001
- book chapter
- Published by Elsevier
- Vol. 132, 391-404
- https://doi.org/10.1016/s0079-6123(01)32090-3
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Kainate receptors activate NF-κB via MAP kinase in striatal neuronesNeuroReport, 2000
- The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alphaNeuropharmacology, 1999
- Drug-Induced Neuroprotection From Global Ischemia Is Associated With Prevention of Persistent but Not Transient Activation of Nuclear Factor-κB in RatsStroke, 1998
- Global Ischemia Activates Nuclear Factor-κB in Forebrain Neurons of RatsStroke, 1997
- Mechanisms that Result in Damage During and Following Cerebral IschemiaNeuroscience & Biobehavioral Reviews, 1997
- Alteration of Transcription Factor Binding Activities in the Ischemic Rat-BrainBiochemical and Biophysical Research Communications, 1995
- Tumor necrosis factor-alpha expression in ischemic neurons.Stroke, 1994
- Involvement of glutamate receptors, lipases, and phospholipases in long‐term potentiation and neurodegenerationJournal of Neuroscience Research, 1994
- p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats.Stroke, 1994
- p53 Expression in brain after middle cerebral artery occlusion in the ratBiochemical and Biophysical Research Communications, 1992